Furthermore, other investigations have shown a significant functional impairment in Treg regulatory activity in MG individuals, with alterations in the inhibitory function of responder T (Tresp) cells mediated by Tregs and a drop in FoxP3 expression, as previously documented [92,94,95,96]. The gene discussed is FOXP3; the disease is myasthenia gravis.